Fusion Antibodies plc (AIM:FAB)
London
· Delayed Price · Currency is GBP · Price in GBX 6.40
+0.10 (1.59%)
Jun 27, 2025, 4:28 PM GMT+1
Fusion Antibodies Market Cap
Fusion Antibodies has a market cap or net worth of 7.16 million as of June 27, 2025. Its market cap has increased by 117.63% in one year.
Market Cap
7.16M
Enterprise Value
6.75M
Revenue
1.80M
Ranking
n/a
PE Ratio
n/a
Stock Price
6.40
Market Cap Chart
Since December 18, 2017, Fusion Antibodies's market cap has decreased from 27.28M to 7.16M, a decrease of -73.75%. That is a compound annual growth rate of -16.28%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 158.54B |
| GSK plc | 56.88B |
| Haleon | 33.99B |
| Smith & Nephew | 9.70B |
| ConvaTec Group | 5.91B |
| Hikma Pharmaceuticals | 4.47B |
| HUTCHMED (China) | 1.87B |
| Genus | 1.34B |